S&P 500   2,969.36 (-0.03%)
DOW   26,840.35 (+0.09%)
QQQ   191.39 (+0.15%)
AAPL   237.63 (+0.60%)
FB   183.81 (-0.21%)
MSFT   139.98 (+0.21%)
GOOGL   1,222.40 (+0.55%)
AMZN   1,727.72 (-0.24%)
GE   8.73 (-0.80%)
TSLA   254.88 (+2.82%)
AMD   29.80 (+0.17%)
T   37.42 (-0.43%)
F   8.81 (+0.34%)
PRI   121.28 (-0.34%)
BAC   29.11 (+0.69%)
GILD   64.68 (+1.08%)
DIS   129.88 (-0.12%)
S&P 500   2,969.36 (-0.03%)
DOW   26,840.35 (+0.09%)
QQQ   191.39 (+0.15%)
AAPL   237.63 (+0.60%)
FB   183.81 (-0.21%)
MSFT   139.98 (+0.21%)
GOOGL   1,222.40 (+0.55%)
AMZN   1,727.72 (-0.24%)
GE   8.73 (-0.80%)
TSLA   254.88 (+2.82%)
AMD   29.80 (+0.17%)
T   37.42 (-0.43%)
F   8.81 (+0.34%)
PRI   121.28 (-0.34%)
BAC   29.11 (+0.69%)
GILD   64.68 (+1.08%)
DIS   129.88 (-0.12%)
Log in

Flexion Therapeutics News Headlines (NASDAQ:FLXN)

$14.37
+1.01 (+7.56 %)
(As of 10/14/2019 11:18 AM ET)
Today's Range
$12.75
Now: $14.37
$14.38
50-Day Range
$10.93
MA: $13.47
$15.41
52-Week Range
$8.76
Now: $14.37
$19.82
Volume22,755 shs
Average Volume563,787 shs
Market Capitalization$547.64 million
P/E RatioN/A
Dividend YieldN/A
Beta1.34

Headlines

Flexion Therapeutics (NASDAQ FLXN) News Headlines

Source:
DateHeadline
Flexion Therapeutics Announces Extended FDA Review of Supplemental New Drug Application for ZILRETTA®Flexion Therapeutics Announces Extended FDA Review of Supplemental New Drug Application for ZILRETTA®
finance.yahoo.com - October 14 at 8:36 AM
Flexion: Buying Before And After ZILRETTAs PDUFAFlexion: Buying Before And After ZILRETTA's PDUFA
seekingalpha.com - October 12 at 9:32 AM
Do Options Traders Know Something About Flexion Therapeutics (FLXN) Stock We Dont?Do Options Traders Know Something About Flexion Therapeutics (FLXN) Stock We Don't?
finance.yahoo.com - October 11 at 4:52 PM
Do Options Traders Know Something About Flexion Therapeutics (FLXN) Stock We Don't?Do Options Traders Know Something About Flexion Therapeutics (FLXN) Stock We Don't?
finance.yahoo.com - October 11 at 11:51 AM
Flexion Therapeutics Target of Unusually High Options Trading (NASDAQ:FLXN)Flexion Therapeutics Target of Unusually High Options Trading (NASDAQ:FLXN)
www.americanbankingnews.com - October 8 at 6:23 AM
Zacks: Brokerages Anticipate Flexion Therapeutics Inc (NASDAQ:FLXN) Will Post Quarterly Sales of $18.85 MillionZacks: Brokerages Anticipate Flexion Therapeutics Inc (NASDAQ:FLXN) Will Post Quarterly Sales of $18.85 Million
www.americanbankingnews.com - October 5 at 2:42 AM
Health Check: How Prudently Does Flexion Therapeutics (NASDAQ:FLXN) Use Debt?Health Check: How Prudently Does Flexion Therapeutics (NASDAQ:FLXN) Use Debt?
finance.yahoo.com - October 4 at 4:13 PM
-$1.01 Earnings Per Share Expected for Flexion Therapeutics Inc (NASDAQ:FLXN) This Quarter-$1.01 Earnings Per Share Expected for Flexion Therapeutics Inc (NASDAQ:FLXN) This Quarter
www.americanbankingnews.com - October 3 at 9:36 PM
Former NY Yankees Outfielder Chris Dickerson Teams Up With Flexion Therapeutics to Raise Awareness of Impact of Osteoarthritis (OA)Former NY Yankees Outfielder Chris Dickerson Teams Up With Flexion Therapeutics to Raise Awareness of Impact of Osteoarthritis (OA)
finance.yahoo.com - October 2 at 3:42 PM
Flexion Therapeutics Inc (NASDAQ:FLXN) Receives Consensus Recommendation of "Buy" from AnalystsFlexion Therapeutics Inc (NASDAQ:FLXN) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - September 29 at 5:55 PM
Flexion Therapeutics Target of Unusually Large Options Trading (NASDAQ:FLXN)Flexion Therapeutics Target of Unusually Large Options Trading (NASDAQ:FLXN)
www.americanbankingnews.com - September 24 at 8:57 AM
Flexion Therapeutics Sponsors a Memorial to the Victims of the Opioid Crisis to Raise Awareness of the Tragic Consequences of the Opioid Epidemic Across the U.S.Flexion Therapeutics Sponsors a Memorial to the Victims of the Opioid Crisis to Raise Awareness of the Tragic Consequences of the Opioid Epidemic Across the U.S.
finance.yahoo.com - September 23 at 3:35 PM
Flexion Therapeutics: Zilrettas Uptake ImprovesFlexion Therapeutics: Zilretta's Uptake Improves
seekingalpha.com - September 11 at 4:32 PM
Flexion Therapeutics, Inc. (FLXN) Shares March Higher, Can It Continue?Flexion Therapeutics, Inc. (FLXN) Shares March Higher, Can It Continue?
finance.yahoo.com - September 5 at 1:57 PM
Need To Know: Flexion Therapeutics, Inc. (NASDAQ:FLXN) Insiders Have Been Buying SharesNeed To Know: Flexion Therapeutics, Inc. (NASDAQ:FLXN) Insiders Have Been Buying Shares
finance.yahoo.com - September 4 at 10:26 AM
Flexion Therapeutics to Present at the Wells Fargo Securities 2019 Healthcare ConferenceFlexion Therapeutics to Present at the Wells Fargo Securities 2019 Healthcare Conference
finance.yahoo.com - August 29 at 11:41 AM
Flexion Therapeutics: Holding Its OwnFlexion Therapeutics: Holding Its Own
seekingalpha.com - August 24 at 6:12 PM
Flexion Therapeutics, Inc. (FLXN) Q2 2019 Earnings Call TranscriptFlexion Therapeutics, Inc. (FLXN) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 7 at 8:16 PM
Edited Transcript of FLXN earnings conference call or presentation 6-Aug-19 8:30pm GMTEdited Transcript of FLXN earnings conference call or presentation 6-Aug-19 8:30pm GMT
finance.yahoo.com - August 7 at 8:16 PM
Flexion up 15% premarket on Zilretta rampFlexion up 15% premarket on Zilretta ramp
seekingalpha.com - August 7 at 11:34 AM
Flexion Therapeutics EPS beats by $0.09, beats on revenueFlexion Therapeutics EPS beats by $0.09, beats on revenue
seekingalpha.com - August 6 at 10:41 PM
Flexion Therapeutics, Inc. (FLXN) CEO Mike Clayman on Q2 2019 Results - Earnings Call TranscriptFlexion Therapeutics, Inc. (FLXN) CEO Mike Clayman on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 10:41 PM
Flexion Therapeutics Reports Second-Quarter 2019 Financial Results and Recent Business HighlightsFlexion Therapeutics Reports Second-Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - August 6 at 10:41 PM
Flexion Therapeutics (FLXN) Reports Q2 Loss, Tops Revenue EstimatesFlexion Therapeutics (FLXN) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 6 at 10:41 PM
How Should Investors Feel About Flexion Therapeutics, Inc.'s (NASDAQ:FLXN) CEO Pay?How Should Investors Feel About Flexion Therapeutics, Inc.'s (NASDAQ:FLXN) CEO Pay?
finance.yahoo.com - August 5 at 9:42 AM
Flexion: The Time To Buy Is NowFlexion: The Time To Buy Is Now
seekingalpha.com - July 31 at 9:31 AM
Flexion Therapeutics: The Time To Buy Is NowFlexion Therapeutics: The Time To Buy Is Now
seekingalpha.com - July 31 at 9:31 AM
Will Flexion Therapeutics (FLXN) Report Negative Q2 Earnings? What You Should KnowWill Flexion Therapeutics (FLXN) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 30 at 8:01 PM
Flexion Therapeutics to Report Second-Quarter 2019 Financial Results on August 6, 2019Flexion Therapeutics to Report Second-Quarter 2019 Financial Results on August 6, 2019
finance.yahoo.com - July 30 at 8:01 PM
Flexion up 3% on new Zilretta dataFlexion up 3% on new Zilretta data
seekingalpha.com - July 15 at 6:22 PM
Flexion Therapeutics Presents New Data Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in Patients with Advanced Knee OAFlexion Therapeutics Presents New Data Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in Patients with Advanced Knee OA
finance.yahoo.com - July 15 at 8:55 AM
Flexion Therapeutics, Inc. (NASDAQ:FLXN): When Will It Breakeven?Flexion Therapeutics, Inc. (NASDAQ:FLXN): When Will It Breakeven?
finance.yahoo.com - July 5 at 8:56 AM
Flexion: Finally Looking For An EntryFlexion: Finally Looking For An Entry
seekingalpha.com - June 17 at 7:26 PM
Flexion Therapeutics nabs new patent in U.S.Flexion Therapeutics nabs new patent in U.S.
seekingalpha.com - June 5 at 6:36 PM
Flexion Therapeutics Announces Issuance of New U.S. Patent Covering FX201 a Gene Therapy Product Candidate for the Treatment of OsteoarthritisFlexion Therapeutics Announces Issuance of New U.S. Patent Covering FX201 a Gene Therapy Product Candidate for the Treatment of Osteoarthritis
finance.yahoo.com - June 5 at 8:40 AM
If You Had Bought Flexion Therapeutics (NASDAQ:FLXN) Stock A Year Ago, Youd Be Sitting On A 56% Loss, TodayIf You Had Bought Flexion Therapeutics (NASDAQ:FLXN) Stock A Year Ago, You'd Be Sitting On A 56% Loss, Today
finance.yahoo.com - May 30 at 8:55 AM
If You Had Bought Flexion Therapeutics (NASDAQ:FLXN) Stock A Year Ago, You'd Be Sitting On A 56% Loss, TodayIf You Had Bought Flexion Therapeutics (NASDAQ:FLXN) Stock A Year Ago, You'd Be Sitting On A 56% Loss, Today
finance.yahoo.com - May 30 at 8:55 AM
Flexion Therapeutics: The Bottom Could Now Be InFlexion Therapeutics: The Bottom Could Now Be In
seekingalpha.com - May 15 at 8:03 PM
Flexion Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare ConferenceFlexion Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - May 14 at 7:38 PM
Here’s What Hedge Funds Think About Flexion Therapeutics Inc (FLXN)Here’s What Hedge Funds Think About Flexion Therapeutics Inc (FLXN)
finance.yahoo.com - May 13 at 8:49 AM
Flexion Therapeutics, Inc. (FLXN) Q1 2019 Earnings Call TranscriptFlexion Therapeutics, Inc. (FLXN) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 10 at 6:31 PM
Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
finance.yahoo.com - May 10 at 8:55 AM
Flexion up 14% premarket on Zilretta rampFlexion up 14% premarket on Zilretta ramp
seekingalpha.com - May 9 at 7:17 PM
Here's Why Flexion Therapeutics Jumped as Much as 18.4% TodayHere's Why Flexion Therapeutics Jumped as Much as 18.4% Today
finance.yahoo.com - May 9 at 7:17 PM
Sarepta a "Fresh Pick" at Baird in premarket analyst actionSarepta a "Fresh Pick" at Baird in premarket analyst action
seekingalpha.com - May 9 at 8:51 AM
Edited Transcript of FLXN earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of FLXN earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 8:51 AM
Flexion Therapeutics Reports First-Quarter 2019 Financial Results and Recent Business HighlightsFlexion Therapeutics Reports First-Quarter 2019 Financial Results and Recent Business Highlights
www.globenewswire.com - May 8 at 7:15 PM
Flexion Therapeutics EPS in-line, misses on revenueFlexion Therapeutics EPS in-line, misses on revenue
seekingalpha.com - May 8 at 7:15 PM
Flexion Therapeutics (FLXN) Reports Q1 Loss, Lags Revenue EstimatesFlexion Therapeutics (FLXN) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 8 at 7:15 PM
Flexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI) World CongressFlexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI) World Congress
finance.yahoo.com - May 2 at 7:38 PM
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel